Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004
A. David McCollum, MD
Since the article has no abstract, the first paragraph is shown.
Colon cancer remains a major cause of cancer-related morbidity and mortality. In the USA, it is estimated that 106,680 new cases will be diagnosed and that 55,170 deaths will be attributed to the disease in 2006 (1). The stage of disease at the time of diagnosis is the single most important factor for predicting survival from the disease. In early stages, colon cancer is eminently curable, with expected 5-year survival rates of 90% or better. However, if the disease is more advanced at the time of diagnosis, the outlook is not nearly as favorable. In patients with advanced or metastatic disease at presentation, the chance of 5-year survival drops below 10% (2).
|
Baylor Intranet | 
Baylor Portal